Novo Nordisk

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Novo Nordisk and other ETFs, options, and stocks.

About NVO

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care, and Rare Disease segments. 

CEO
Lars Fruergaard Jørgensen
CEOLars Fruergaard Jørgensen
Employees
63,370
Employees63,370
Headquarters
Bagsværd, Capital Region
HeadquartersBagsværd, Capital Region
Founded
1931
Founded1931
Employees
63,370
Employees63,370

NVO Key Statistics

Market cap
572.02B
Market cap572.02B
Price-Earnings ratio
47.28
Price-Earnings ratio47.28
Dividend yield
0.57%
Dividend yield0.57%
Average volume
4.14M
Average volume4.14M
High today
$130.16
High today$130.16
Low today
$127.00
Low today$127.00
Open price
$128.47
Open price$128.47
Volume
3.66M
Volume3.66M
52 Week high
$138.28
52 Week high$138.28
52 Week low
$75.56
52 Week low$75.56

NVO News

Business Insider 8h
Bernie Sanders wants to make Ozempic cheaper - Business Insider

Sen. Bernie Sanders said the price of Ozempic is "outrageously high." He wants to meet with Novo Nordisk's CEO, Bloomberg reports. A recent study found that O...

Bernie Sanders wants to make Ozempic cheaper - Business Insider
Fortune 9h
'Outrageous': Bernie Sanders has Ozempic demands after study says it costs just $5 per month to manufacture - Fortune

Senator Bernie Sanders wants to meet next week with Novo Nordisk A/S’s top executive about lowering the price of its blockbuster drug Ozempic, fueling controver...

'Outrageous': Bernie Sanders has Ozempic demands after study says it costs just $5 per month to manufacture - Fortune
Benzinga 13h
How Much Does It Cost To Make Novo Nordisk's Ozempic? Shockingly Low Against $1,000 Price Tag, Study Shows

Loading... Loading... A recent study suggests that despite Novo Nordisk A/S’s NVO high monthly charge of close to $1,000 for its blockbuster diabetes drug Ozem...

How Much Does It Cost To Make Novo Nordisk's Ozempic? Shockingly Low Against $1,000 Price Tag, Study Shows

Analyst ratings

63%

of 30 ratings
Buy
63.3%
Hold
26.7%
Sell
10%

More NVO News

Bloomberg 13h
Bernie Sanders Wants to Meet Novo CEO Next Week on Ozempic Price - Bloomberg

Senator Bernie Sanders wants to meet next week with Novo Nordisk A/S’s top executive about lowering the price of its blockbuster drug Ozempic , fueling controve...

Bernie Sanders Wants to Meet Novo CEO Next Week on Ozempic Price - Bloomberg
TipRanks 15h
Novo Nordisk Under Fire, Post-Ozempic Study - TipRanks.com - TipRanks

Healthcare major Novo Nordisk (NYSE:NVO) has come under fire following a study indicating that NVO’s popular diabetes drug Ozempic can be manufactured for less...

Benzinga 15h
Elevance, CVS Health Are First Medicare Insurers To Cover Novo Nordisk's Weight Loss Sensation Wegovy

Loading... Loading... Some major U.S. health insurers, including CVS Health Inc CVS, Elevance Health Inc ELV and Kaiser Permanente, will start reimbursing for...

Elevance, CVS Health Are First Medicare Insurers To Cover Novo Nordisk's Weight Loss Sensation Wegovy
Fortune 15h
Ozempic maker Novo Nordisk facing pressure as study finds $1000 appetite suppressant can be made for just $5 - Fortune

Ozempic could be profitably produced for less than $5 a month even as maker Novo Nordisk A/S charges almost $1,000 in the US, according to a study that revives...

Ozempic maker Novo Nordisk facing pressure as study finds $1000 appetite suppressant can be made for just $5 - Fortune
Benzinga 16h
What the Options Market Tells Us About Novo Nordisk - Novo Nordisk - Benzinga

Loading... Loading... Deep-pocketed investors have adopted a bearish approach towards Novo Nordisk NVO, and it's something market players shouldn't ignore. Our...

What the Options Market Tells Us About Novo Nordisk - Novo Nordisk - Benzinga
CNBC 2d
Novo Nordisk's $1,000 diabetes drug Ozempic can be made for less than $5 a month, study suggests

The blockbuster diabetes drug Ozempic could be manufactured for less than $5 a month, even as Novo Nordisk charges close to $1,000 per month for the injection i...

Novo Nordisk's $1,000 diabetes drug Ozempic can be made for less than $5 a month, study suggests
Yahoo Finance 2d
Viking Up 17% on Encouraging Oral Obesity Drug Data - Yahoo Finance

Shares of Viking Therapeutics VKTX were up 16.8% on Mar 26 after it announced positive data from an early-stage study that an oral formulation of VK2735, its in...

Viking Up 17% on Encouraging Oral Obesity Drug Data - Yahoo Finance
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.